Business Responsibility and Sustainability Report of the Company for the Financial Year 2025-26

August 01, 2026 BSE Limited National Stock Exchange of India Limited Floor 25, P. J. Towers Exchange Plaza Dalal Street, Fort Bandra Kurla Complex, Bandra (E) Mumbai - 400 001 Mumbai - 400 051 Scrip Code: 543271 Trading Symbol: JUBLINGREA Sub.: Business Responsibility and Sustainability Report (‘BRSR’) for the Financial Year 2025-26 Dear Sir/Madam, Pursuant to the Regulation 34(2)(f) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are submitting herewith the Business Responsibility and Sustainability Report for the Financial Year 2025-26, which also forms part of the Annual Report for the Financial Year 2025-26. This is for your information and record. Thanking You Yours faithfully, For Jubilant Ingrevia Limited Deepanjali Gulati Company Secretary & Compliance Officer Encl: As above Business Responsibility & Jubilant Ingrevia Limited Sustainability Reporting Business Responsibility & Sustainability Reporting SECTION A: GENERAL DISCLOSURES I. Details of the listed entity 1. Corporate Identity Number (CIN) of the Listed Entity L24299UP2019PLC122657 2. Name of the Listed Entity JUBILANT INGREVIA LIMITED 3. Year of incorporation 23-10-2019 4. Registered office address Bhartiagram, Gajraula, District Amroha-244 223, Uttar Pradesh, India 5. Corporate address Jubilant Ingrevia Limited, 1A, Sector 16A, Noida - 201 301, Uttar Pradesh, India 6. E-mail ESGCommunications@jubl.com 7. Telephone 91-120-4361502 8. Website www.jubilantingrevia.com 9. Financial year for which reporting is being done Financial year for which reporting is being done Start Date End Date Current Financial Year 01-04-2025 31-03-2026 Previous Financial Year 01-04-2024 31-03-2025 Prior to the Previous Financial year 01-04-2023 31-03-2024 10. Name of the Stock Exchange(s) where shares are listed National Stock Exchange of India Limited; BSE Limited 11. Paid-up Capital 157.72 million 12. Name and contact details (telephone, email address) of the person who may be contacted in case of any queries on the BRSR report Mr. Vijay Kumar Srivastava Chief of Operations & Whole Time Director 1-A, Sector 16A, Noida -201301 Uttar Pradesh, India. Phone: +91-120-4958033 Email: ESGCommunications@jubl.com 13. Reporting boundary - Are the disclosures under this report made on a standalone basis (i.e. only for the entity) or on a consolidated basis (i.e. for the entity and all the entities which form a part of its consolidated financial statements, taken together). Disclosures are on a consolidated basis including Indian subsidiaries (excluded foreign subsidiaries) and excluding Associates. 14. Name of assurance provider: NA 15. Type of assurance obtained: NA Annual Report 2025-26 II. Products/services 16. Details of business activities (accounting for 90% of the turnover): S. % of Turnover Description of Main Activity Description of Business Activity No. of the entity 1 Speciality Chemicals Manufacturing, Distribution, Sales & Marketing 44.13% 2 Chemical Intermediates 37.87% 3 Nutrition and Health Solutions 18% 17. Products/Services sold by the entity (accounting for 90% of the entity’s Turnover): S. % of total Turnover Product/Service NIC Code No. contributed 1 Pyridine & Picolines, Fine Chemicals, Crop 2021 44.13% protection chemicals and CDMO 2 Nutrition & Health Ingredients, Animal Nutrition & Health solutions 2011 37.87% and Human Nutrition & Health solution 3 Acetyls and Specialty Ethanol 2011 18% NIC Code list link: https://www.ncs.gov.in/Documents/NIC_Sector.pdf III. Operations 18. Number of locations where plants and/or operations/offices of the entity are situated: Location Number of plants Number of offices Total National 6* 8 14 International 0 4 4 *1 plant acquired in March 30th 2026 19. Markets served by the entity: a. Number of locations Locations Number National (No. of States) 25 International (No. of Countries) 62 b. What is the contribution of exports as a percentage of the total turnover of the entity? The contribution of export (consolidated) as a percentage of the total turnover of the entity during FY 2026 was 44.32%. c. A brief on types of customers Jubilant Ingrevia Limited is a leading solutions provider of Specialty Chemicals & CDMO globally, serving Pharmaceutical, Nutrition, Agrochemical, Consumer, Semiconductor and Industrial customers. It offers customised solutions that are innovative, cost-effective and conform to global quality standards and has a broad portfolio of 130+ products. It has over 45 years of legacy in the chemicals industry and is amongst the top players globally in Pyridine & Picolines, Pyridine derivatives, Acetic Anhydride, Vitamin-B3 and many other products. Jubilant Ingrevia Limited has a fast-growing Custom Development and Manufacturing business (CDMO) serving pharmaceuticals, agrochemicals and semiconductor sectors. The Company serves customers in US, EU, Japan, Middle East, South East Asia and other geographies, in addition to domestic market from its 50+ plants across 6 manufacturing facilities in India with a workforce of over 2,300 employees. Its three R&D centres employ 150 scientists working on cutting-edge research and innovation. Jubilant Ingrevia Limited is a Responsible Care certified company and ranked highly in global ESG indices such as Ecovadis and Dow Jones Sustainability Index. In 2024, Jubilant Ingrevia Limited was also recognised by the World Economic Forum (WEF) and entered its prestigious Global Lighthouse Network (GLN) for deployment of 4IR technologies. Business Responsibility & Jubilant Ingrevia Limited Sustainability Reporting IV. Employees 20. Details as of the end of the Financial Year: a. Employees and workers (including differently abled): S. Total Male Female Other Particulars No. (A) No. (B) % (B/A) No. (C) % (C/A) No. (H) % (H/A) EMPLOYEES 1. Permanent (D) 1951 1814 92.97 137 7.02 0 0 2. Other than Permanent (E) 0 0 0 0 0 0 0 3. Total employees (D+E) 1951 1814 92.97 137 7.02 0 0 WORKERS 4. Permanent (F) 234 234 100 0 0 0 0 5. Other than Permanent (G)* 1244 1216 98 28 2 0 0 6. Total workers (F + G) 1478 1450 98 28 2 0 0 *Contract workers b. Differently abled Employees and workers: S. Total Male Female Other Particulars No (A) No. (B) % (B/A) No. (C) % (C/A) No. (H) % (H/A) DIFFERENTLY ABLED EMPLOYEES 1. Permanent (D) 0 0 0 0 0 0 0 2. Other than Permanent (E) 0 0 0 0 0 0 0 3. Total differently abled 0 0 0 0 0 0 0 employees (D + E) DIFFERENTLY ABLED WORKERS 4. Permanent (F) 0 0 0 0 0 0 0 5. Other than permanent (G) 2 2 100 0 0 0 0 6. Total differently abled workers 2 2 100 0 0 0 0 (F + G) 21. Participation/Inclusion/Representation of women No. and percentage Total of Females No. (B) % (B / A) Board of Directors 12 2 16.67 Key Management Personnel 5 1 20.00 22. Turnover rate for permanent employees and workers (Disclose trends for the past 3 years) FY 2024 FY 2026 FY 2025 (Turnover rate in the year prior (Turnover rate in current FY) (Turnover rate in previous FY) to the previous FY) Male Female Other Total Male Female Other Total Male Female Other Total Permanent 19.2% 25.2% 0% 19.6% 18.3% 17.10% 0% 18.2% 17.7% 24.6% 0% 18.10% Employees Permanent 9% 0% 0% 9% 8.9% 0% 0% 8.9% 12% 0% 0% 12% Workers Annual Report 2025-26 V. Holding, Subsidiary and Associate Companies (including joint ventures) 23. (a) Names of holding / subsidiary / associate companies / joint ventures Does the entity indicated at Indicate whether Name of the holding / % of shares column A, participate in the S. holding/ Subsidiary/ subsidiary / associate held by listed Business Responsibility No. Associate/ Joint companies / joint ventures (A) entity initiatives of the listed Venture entity? (Yes/No) 1 Jubilant Infrastructure Limited Subsidiary 100 No 2 Jubilant Agro Sciences Limited Subsidiary 100 No 3 Jubilant Life Sciences NV, Belgium Subsidiary 100 No 4 Jubilant Life Sciences International Subsidiary 100 No Pte Ltd, Singapore 5 Jubilant Life Sciences (Shanghai) Subsidiary 100 No Limited 6 Jubilant Ingrevia (USA) Inc. Subsidi [Showing first 8,000 characters — download PDF for full document]